TY - JOUR
T1 - Quality of life after stroke
T2 - a longitudinal analysis of a cluster randomized trial
AU - Orman, Zhomart
AU - Thrift, Amanda G.
AU - Olaiya, Muideen T.
AU - Ung, David
AU - Cadilhac, Dominique A.
AU - Phan, Thanh
AU - Nelson, Mark R.
AU - Srikanth, Velandai K.
AU - Vuong, Jason
AU - Bladin, Christopher F.
AU - Gerraty, Richard P.
AU - Fitzgerald, Sharyn M.
AU - Frayne, Judith
AU - Kim, Joosup
AU - on behalf of the STANDFIRM (Shared Team Approach between Nurses and Doctors For Improved Risk factor Management) Investigators
N1 - Funding Information:
AGT reports being a Board Member of the Stroke Foundation (Australia) and funding from NHMRC. DAC reports grants from NHMRC, the Stroke Foundation and the Heart Foundation. MRN reports being a Member of Research Advisory Board of the Stroke Foundation (Australia), grants from NHMRC and the Heart Foundation, and being on a lipids advisory board for Novartis. All other authors report no potential conflicts of interest.
Funding Information:
The STANDFIRM trial was supported by a National Health and Medical Research Council (NHMRC) project grant (586605). We further acknowledge fellowship support from the NHMRC (AGT 1042600; DAC 1063761).
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature Switzerland AG.
PY - 2022/8
Y1 - 2022/8
N2 - Purpose: Health-related quality of life (QoL) is poor after stroke, but may be improved with comprehensive care plans. We aimed to determine the effects of an individualized management program on QoL in people with stroke or transient ischemic attack (TIA), describe changes in QoL over time, and identify variables associated with QoL. Methods: This was a multicenter, cluster randomized controlled trial with blinded assessment of outcomes and intention‐to‐treat analysis. Patients with stroke or TIA aged ≥ 18 years were randomized by general practice to receive usual care or an intervention comprising a tailored chronic disease management plan and education. QoL was assessed at baseline and 3, 12, and 24 months after baseline using the Assessment of Quality of Life instrument. Patient responses were converted to utility scores ranging from − 0.04 (worse than death) to 1.00 (good health). Mixed-effects models were used for analyses. Results: Among 563 participants recruited (mean age 68.4 years, 64.5% male), median utility scores ranged from 0.700 to 0.772 at different time points, with no difference observed between intervention and usual care groups. QoL improved significantly from baseline to 3 months (ß = 0.019; P = 0.015) and 12 months (ß = 0.033; P < 0.001), but not from baseline to 24 months (ß = 0.013; P = 0.140) in both groups combined. Older age, females, lower educational attainment, greater handicap, anxiety and depression were longitudinally associated with poor QoL. Conclusion: An individualized management program did not improve QoL over 24 months. Those who are older, female, with lower educational attainment, greater anxiety, depression and handicap may require greater support. Clinical trial registration: https://www.anzctr.org.au. Unique identifier: ACTRN12608000166370.
AB - Purpose: Health-related quality of life (QoL) is poor after stroke, but may be improved with comprehensive care plans. We aimed to determine the effects of an individualized management program on QoL in people with stroke or transient ischemic attack (TIA), describe changes in QoL over time, and identify variables associated with QoL. Methods: This was a multicenter, cluster randomized controlled trial with blinded assessment of outcomes and intention‐to‐treat analysis. Patients with stroke or TIA aged ≥ 18 years were randomized by general practice to receive usual care or an intervention comprising a tailored chronic disease management plan and education. QoL was assessed at baseline and 3, 12, and 24 months after baseline using the Assessment of Quality of Life instrument. Patient responses were converted to utility scores ranging from − 0.04 (worse than death) to 1.00 (good health). Mixed-effects models were used for analyses. Results: Among 563 participants recruited (mean age 68.4 years, 64.5% male), median utility scores ranged from 0.700 to 0.772 at different time points, with no difference observed between intervention and usual care groups. QoL improved significantly from baseline to 3 months (ß = 0.019; P = 0.015) and 12 months (ß = 0.033; P < 0.001), but not from baseline to 24 months (ß = 0.013; P = 0.140) in both groups combined. Older age, females, lower educational attainment, greater handicap, anxiety and depression were longitudinally associated with poor QoL. Conclusion: An individualized management program did not improve QoL over 24 months. Those who are older, female, with lower educational attainment, greater anxiety, depression and handicap may require greater support. Clinical trial registration: https://www.anzctr.org.au. Unique identifier: ACTRN12608000166370.
KW - Chronic disease management
KW - Quality of life
KW - Randomized controlled trial
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=85123773539&partnerID=8YFLogxK
U2 - 10.1007/s11136-021-03066-y
DO - 10.1007/s11136-021-03066-y
M3 - Article
C2 - 35067819
AN - SCOPUS:85123773539
SN - 0962-9343
VL - 31
SP - 2445
EP - 2455
JO - Quality of Life Research
JF - Quality of Life Research
IS - 8
ER -